Schedule of Investments
ARK Innovation ETF
October 31, 2024 (Unaudited)
Investments | | Shares | | | Value | |
| | | | | | |
COMMON STOCKS–100.0% | | | | | | |
|
Aerospace & Defense - 1.0% |
Archer Aviation, Inc., Class A*† | | | 16,616,826 | | | $ | 52,343,002 | |
| | | | | | | | |
Automobiles - 14.3% | | | | | | | | |
Tesla, Inc.* | | | 3,115,373 | | | | 778,375,944 | |
| | | | | | | | |
Biotechnology - 15.8% | | | | | | | | |
Beam Therapeutics, Inc.*† | | | 4,410,270 | | | | 96,629,016 | |
CRISPR Therapeutics AG (Switzerland)*† | | | 5,415,578 | | | | 251,228,663 | |
Intellia Therapeutics, Inc.*† | | | 8,605,387 | | | | 122,368,603 | |
Moderna, Inc.* | | | 10,045 | | | | 546,046 | |
Natera, Inc.* | | | 461,220 | | | | 55,789,171 | |
Prime Medicine, Inc.* | | | 2,406,266 | | | | 9,336,312 | |
Recursion Pharmaceuticals, Inc., Class A*† | | | 18,987,925 | | | | 120,003,686 | |
Twist Bioscience Corp.* | | | 2,684,969 | | | | 108,365,349 | |
Veracyte, Inc.* | | | 2,899,646 | | | | 97,834,056 | |
Total Biotechnology | | | | | | | 862,100,902 | |
| | | | | | | | |
Broadline Retail - 1.2% | | | | | | | | |
Amazon.com, Inc.* | | | 343,545 | | | | 64,036,788 | |
| | | | | | | | |
Capital Markets - 11.5% | | | | | | | | |
Coinbase Global, Inc., Class A* | | | 2,173,837 | | | | 389,660,282 | |
Robinhood Markets, Inc., Class A* | | | 10,078,515 | | | | 236,744,318 | |
Total Capital Markets | | | | | | | 626,404,600 | |
| | | | | | | | |
Consumer Finance - 1.6% | | | | | | | | |
SoFi Technologies, Inc.* | | | 7,605,878 | | | | 84,957,657 | |
| | | | | | | | |
Entertainment - 17.2% | | | | | | | | |
ROBLOX Corp., Class A* | | | 7,923,437 | | | | 409,800,162 | |
Roku, Inc.*† | | | 8,214,106 | | | | 526,359,912 | |
Total Entertainment | | | | | | | 936,160,074 | |
| | | | | | | | |
Financial Services - 4.7% | | | | | | | | |
Block, Inc.* | | | 3,571,177 | | | | 258,267,521 | |
| | | | | | | | |
Health Care Equipment & Supplies - 0.4% | | | | | | | | |
Cerus Corp.*† | | | 12,931,823 | | | | 20,302,962 | |
| | | | | | | | |
Hotels, Restaurants & Leisure - 2.2% | | | | | | | | |
DraftKings, Inc., Class A* | | | 3,406,140 | | | | 120,304,865 | |
| | | | | | | | |
Interactive Media & Services - 4.4% | | | | | | | | |
Meta Platforms, Inc., Class A | | | 276,746 | | | | 157,075,495 | |
Pinterest, Inc., Class A* | | | 2,520,695 | | | | 80,132,894 | |
Total Interactive Media & Services | | | | | | | 237,208,389 | |
| | | | | | | | |
IT Services - 3.9% | | | | | | | | |
Shopify, Inc., Class A (Canada)* | | | 2,751,577 | | | | 215,200,837 | |
| | | | | | | | |
Life Sciences Tools & Services - 4.6% | | | | | | | | |
10X Genomics, Inc., Class A*† | | | 8,166,551 | | | | 130,909,813 | |
Pacific Biosciences of California, Inc.*† | | | 18,937,397 | | | | 41,094,151 | |
Tempus AI, Inc.* | | | 1,846,916 | | | | 82,409,392 | |
Total Life Sciences Tools & Services | | | | | | | 254,413,356 | |
| | | | | | | | |
Media - 2.0% | | | | | | | | |
Trade Desk, Inc. (The), Class A* | | | 906,136 | | | | 108,926,608 | |
Investments | | Shares | | | Value | |
|
Semiconductors & Semiconductor Equipment - 3.1% |
Advanced Micro Devices, Inc.* | | | 539,169 | | | $ | 77,678,078 | |
Teradyne, Inc. | | | 851,038 | | | | 90,388,746 | |
Total Semiconductors & Semiconductor Equipment | | | | | | | 168,066,824 | |
| | | | | | | | |
Software - 12.1% | | | | | | | | |
PagerDuty, Inc.*† | | | 7,487,108 | | | | 135,217,171 | |
Palantir Technologies, Inc., Class A* | | | 6,532,658 | | | | 271,508,187 | |
UiPath, Inc., Class A* | | | 13,117,400 | | | | 162,131,064 | |
Unity Software, Inc.* | | | 4,399,428 | | | | 88,340,514 | |
Total Software | | | | | | | 657,196,936 | |
Total Common Stocks | | | | | | | | |
(Cost $8,974,958,829) | | | | | | | 5,444,267,265 | |
MONEY MARKET FUND–0.4% | | | | | | | | |
Goldman Sachs Financial Square Treasury Obligations Fund, 4.74% (a) | | | | | | | | |
(Cost $20,358,820) | | | 20,358,820 | | | | 20,358,820 | |
Total Investments–100.4% | | | | | | | | |
(Cost $8,995,317,649) | | | | | | | 5,464,626,085 | |
Liabilities in Excess of Other Assets–(0.4)% | | | | | | | (20,546,738 | ) |
Net Assets–100.0% | | | | | | $ | 5,444,079,347 | |
| * | Non-income producing security |
| (a) | Rate shown represents annualized 7-day yield as of October 31, 2024. |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2024 (Unaudited)
Affiliated Issuer Transactions
An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities, or a company that is under common ownership or control. Period-to-date transactions with companies which are or were affiliates are as follows:
Value ($) at 7/31/2024 | | | Purchases Cost ($) | | | Sales Proceeds ($) | | | Net Realized Gain/(Loss) ($) | | | Net Change in Unrealized Appreciation (Depreciation) ($) | | | Dividend Income ($) | | | Capital Gain Distributions ($) | | | Number of Shares at 10/31/2024 | | | Value ($) at 10/31/2024 | |
Common Stocks — 27.5% |
Aerospace & Defense — 1.0% |
Archer Aviation, Inc. |
| | | 65,008,132 | | | | 17,843,712 | | | | (14,410,725 | ) | | | (2,964,984 | ) | | | (13,133,133 | ) | | | – | | | | – | | | | 16,616,826 | | | | 52,343,002 | |
Biotechnology — 10.8% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Beam Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 155,963,970 | | | | 25,849,777 | | | | (39,643,903 | ) | | | (46,111,446 | ) | | | 570,618 | | | | – | | | | – | | | | 4,410,270 | | | | 96,629,016 | |
CRISPR Therapeutics AG | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 302,476,878 | | | | 79,089,393 | | | | (71,461,620 | ) | | | (4,801,872 | ) | | | (54,074,116 | ) | | | – | | | | – | | | | 5,415,578 | | | | 251,228,663 | |
Intellia Therapeutics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 218,386,385 | | | | 54,590,924 | | | | (49,708,014 | ) | | | (1,083,111 | ) | | | (99,817,581 | ) | | | – | | | | – | | | | 8,605,387 | | | | 122,368,603 | |
Recursion Pharmaceuticals, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 140,475,692 | | | | 45,435,573 | | | | (33,189,388 | ) | | | 647,419 | | | | (33,365,610 | ) | | | – | | | | – | | | | 18,987,925 | | | | 120,003,686 | |
Twist Bioscience Corp. ^ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 165,426,030 | | | | 28,100,632 | | | | (40,524,472 | ) | | | (19,032,488 | ) | | | (25,604,353 | ) | | | – | | | | – | | | | 2,684,969 | | | | 108,365,349 | |
Veracyte, Inc. ^ | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 92,262,048 | | | | 18,487,430 | | | | (47,140,650 | ) | | | (13,745,043 | ) | | | 47,970,271 | | | | – | | | | – | | | | 2,899,646 | | | | 97,834,056 | |
Entertainment — 9.7% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Roku, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 512,438,347 | | | | 129,053,365 | | | | (172,932,579 | ) | | | (31,964,700 | ) | | | 89,765,479 | | | | – | | | | – | | | | 8,214,106 | | | | 526,359,912 | |
Health Care Equipment & Supplies — 0.4% | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Cerus Corp. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 22,993,572 | | | | 9,912,422 | | | | (5,573,962 | ) | | | (3,681,528 | ) | | | (3,347,542 | ) | | | – | | | | – | | | | 12,931,823 | | | | 20,302,962 | |
Life Sciences Tools & Services — 3.1% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
10X Genomics, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 163,159,368 | | | | 45,192,982 | | | | (44,687,011 | ) | | | 6,303,112 | | | | (39,058,638 | ) | | | – | | | | – | | | | 8,166,551 | | | | 130,909,813 | |
Pacific Biosciences of California, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 38,446,666 | | | | 9,184,296 | | | | (8,597,705 | ) | | | (7,220,458 | ) | | | 9,281,352 | | | | – | | | | – | | | | 18,937,397 | | | | 41,094,151 | |
Software — 2.5% | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
PagerDuty, Inc. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | 167,426,710 | | | | 30,938,232 | | | | (40,557,709 | ) | | | (1,290,394 | ) | | | (21,299,668 | ) | | | – | | | | – | | | | 7,487,108 | | | | 135,217,171 | |
| | $ | 2,044,463,798 | | | $ | 493,678,738 | | | $ | (568,427,738 | ) | | $ | (124,945,493 | ) | | $ | (142,112,921 | ) | | $ | – | | | $ | – | | | | 115,357,586 | | | $ | 1,702,656,384 | |
^ | As of October 31, 2024, the company was no longer considered to be an affiliated security. |
Schedule of Investments (continued)
ARK Innovation ETF
October 31, 2024 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 — Quoted prices in active markets for identical assets.
• Level 2 — Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of October 31, 2024, based upon the three levels defined above:
ARK Innovation ETF | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Assets | | | | | | | | | | | | |
Common Stocks‡ | | $ | 5,444,267,265 | | | $ | – | | | $ | – | | | $ | 5,444,267,265 | |
Money Market Fund | | | 20,358,820 | | | | – | | | | – | | | | 20,358,820 | |
Total | | $ | 5,464,626,085 | | | $ | – | | | $ | – | | | $ | 5,464,626,085 | |
| ‡ | Please refer to the Schedule of Investments to view securities segregated by industry type. |